Fund Holdings — Decheng Capital LLC

Total Portfolio Value:
$685.07M
Total Bought:
$0
Total Sold:
$24.12M
Net Transaction:
-$24.12M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
CG Oncology, Inc.(CGON)6,371,6696,371,6690$452.71M$451.69M65.93%-$1.02M
Nuvation Bio Inc.(NUVB)25,954,43925,954,4390$147.42M$145.34M21.22%-$2.08M
Aclaris Therapeutics, Inc.4,041,7364,041,7360$21.38M$21.26M3.10%-$121.3K
Aardvark Therapeutics Inc3,917,2993,917,2990$22.56M$20.64M3.01%-$1.92M
Upstream Bio Inc.2,724,8682,724,8680$18.86M$14.36M2.10%-$4.50M
Arcus Biosciences, Inc.(RCUS)464,779425,079-39,700$14.33M$10.98M1.60%-$3.35M
Equillium Inc.4,447,3084,447,3080$14.23M$7.23M1.05%-$7.00M
Lyell Immunopharma, Inc.692,050692,0500$9.72M$6.78M0.99%-$2.95M
Zentalis Pharmaceuticals Inc.1,323,3271,323,3270$6.42M$3.67M0.54%-$2.75M
BeyondSpring Inc.SHS3,800,7023,065,702-735,000$6.65M$2.36M0.34%-$4.29M
Pyxis Oncology, Inc (formerly Apexigen)326,810326,8100$983.7K$761.5K0.11%-$222.2K
Newamsterdam Pharma Co Nv
ORDINARY SHARES
176,8870-176,887$5.99M$0—-$5.99M
Revolution Medicines, Inc.(RVMD)52,6670-52,667$9.86M$0—-$9.86M
Tango Therapeutics, Inc.(TNGX)20,0000-20,000$625.2K$0—-$625.2K
Page 1 of 1
Decheng Capital LLC — 13F Holdings — Q3 2026 | TickerTrail